Last update: 15th October 2019

See our latest guidance document to improve corporate reputation:
The provision of drug-treatment information is one of the important nine attributes that contribute to patient centricity
PatientView has therefore produced for industry an evidence-based guidance document on how to improve
drug-treatment information from a patient perspective.
Feedback was collated from 2,000 patient groups during 2018-2019,
including a July-August 2019 survey of 280 patient groups on the specific subject of drug-treatment information.

FOR PRODUCT PRICES 2020 PLEASE CLICK 'HERE'

PATIENTVIEW'S AREAS OF EXPERTISE

• BEING PATIENT-CENTRIC
Guidance documents to improve corporate reputation and patient centricity

Patient groups from different countries and therapy areas define what it is they need from companies to improve this corporate reputation
and be patient-centric

• CORPORATE REPUTATION REPORTS PUBLISHED IN 2019
The corporate reputation of the
pharmaceutical industry from a patient perspective

Patient groups from different countries and therapy areas review the performance of the healthcare industry at key activities that influence effective patient-centricity and therefore corporate reputation

• MYHEALTHAPPS
Curating health apps

• ..by
• • curating health apps recommended by patients/patient groups
  
• • highlighting the views of patients/patient groups on e-health and m-health

• BENCHMARKING
Benchmarking the patient movement

Surveying patient organisations, which tell us about their strengths and weaknesses and where they need the most support

 • RESEARCH WORK
and projects

By surveying our datalisting of 40,000 + patient groups, PatientView can answer a wide range of questions posed by our clients, which come from all parts of the healthcare spectrum

who we are

CONTACT US

For further information about PatientView research and reports please contact us via email either here or on our contact page